Morgan Stanley analyst Greg Parrish upgrades Stride (NYSE:LRN) from Equal-Weight to Overweight and announces $45 price target.
Morgan Stanley Upgrades Stride to Overweight, Announces $45 Price Target
Morgan Stanley analyst Greg Parrish upgrades Stride (NYSE:LRN) from Equal-Weight to Overweight and announces $45 price target.
Related Posts
What 8 Analyst Ratings Have To Say About WalkMe
Over the past 3 months, 8 analysts have published their opinion on WalkMe (NASDAQ:WKME) stock. These analysts are…
Why Lam Research (LRCX) Stock Is Moving
Lam Research Corporation (NASDAQ: LRCX) shares are trading higher by 6.11% to $514.73 Wednesday afternoon.
Shares of semiconductor companies are trading higher in sympathy with Micron, which said customer inventories have declined in several end markets.
Arthur J. Gallagher & Co. Acquires Rosenzweig Insurance Agency; Terms Not Disclosed
Arthur J. Gallagher & Co. today announced the acquisition of Mineola, New York-based Rosenzweig Insurance Agency, Inc. Terms of the transaction were not disclosed.Rosenzweig Insurance Agency is a full-service